We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+13.27%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$437M
AUM Growth
+$49.4M
Cap. Flow
-$2.17M
Cap. Flow %
-0.5%
Top 10 Hldgs %
60.21%
Holding
38
New
7
Increased
8
Reduced
12
Closed
7

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$16.9M
2
EW icon
Edwards Lifesciences
EW
+$13.4M
3
ILMN icon
Illumina
ILMN
+$10.1M
4
THC icon
Tenet Healthcare
THC
+$9.06M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.26M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$22.7M
2
BIIB icon
Biogen
BIIB
+$11.4M
3
CI icon
Cigna
CI
+$8.94M
4
MRK icon
Merck
MRK
+$5.51M
5
SAGE
Sage Therapeutics
SAGE
+$4.53M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNTX icon
26
BioNTech
BNTX
$23.3B
$3.57M 0.82%
+23,738
New +$3.65M
PTCT icon
27
PTC Therapeutics
PTCT
$6.47B
$3.31M 0.76%
86,692
– –
ACAD icon
28
Acadia Pharmaceuticals
ACAD
$4.3B
$2.96M 0.68%
+185,835
New +$2.9M
CTLT
29
DELISTED
CATALENT, INC.
CTLT
$2.48M 0.57%
+55,000
New +$2.99M
VIR icon
30
Vir Biotechnology
VIR
$1.56B
$2.27M 0.52%
89,808
– –
RARE icon
31
Ultragenyx Pharmaceutical
RARE
$2.81B
$2.11M 0.48%
45,520
– –
ALNY icon
32
Alnylam Pharmaceuticals
ALNY
$36.4B
– –
-6,921
Closed -$1.39M
EMBC icon
33
Embecta
EMBC
$204M
– –
-5,246
Closed -$151K
NVAX icon
34
Novavax
NVAX
$1.3B
– –
-56,735
Closed -$1.03M
RIGL icon
35
Rigel Pharmaceuticals
RIGL
$734M
– –
-134,690
Closed -$1.59M
SAGE
36
DELISTED
Sage Therapeutics
SAGE
– –
-115,696
Closed -$4.53M
UHS icon
37
Universal Health Services
UHS
$9.12B
– –
-27,077
Closed -$2.39M
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-68,612
Closed -$3.19M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2022 Portfolio in Review

As of Q4 2022, Sector Gamma AS held 38 positions worth $437M, up 13% from $388M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS's Q4 2022 filing shows 7 new, 8 increased, 12 reduced and 7 closed positions. Its largest new stake was Labcorp: 86,713 shares worth $17.5M. The largest sale was Gilead Sciences, an estimated $22.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q4 2022 buy was Labcorp: 86,713 shares worth $17.5M.
  • Sector Gamma AS added most to BioMarin Pharmaceuticals in Q4 2022, an estimated $4.26M increase.
  • Sector Gamma AS's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $22.7M.
  • Sector Gamma AS fully exited Sage Therapeutics in Q4 2022, selling an estimated $4.53M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $437M portfolio in Q4 2022.
  • Sector Gamma AS opened 7 new positions and closed 7 in Q4 2022.
  • Sector Gamma AS's portfolio value rose 13% quarter-over-quarter to $437M.

Based on Sector Gamma AS's 13F filing for Q4 2022, filed 7 Feb 2023.